Roche Considers Bid To Invest In Full Stake In Genentech
Regardless of posting unfavorable sales growth in 2020, Roche claimed the major spot in this year’s report backed by $50.four billion of income in its pharmaceuticals division. Sales dipped eight% due to biosimilar erosion—strongest in the U.S.—and the impact of COVID-19, which reduced hospitalizations and outpatient visits. The ePlex product performs multiplex testing and also improves the speed of diagnosis as it entirely automates the lab testing process. The traditional testing strategy normally takes six-24 hours whereas the ePlex can…